Default company panoramic image
7c1220a4 93fc 40b2 ab0c c2ca607fd167

Immune Modulation, Inc.

Immune Modulation, Inc. develops therapeutics from natural resources for use as anti -cancer, anti-inflammatory and anti-parasitic agents.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Bloomington, CA, USA
  • Currency USD
  • Founded November 1995
  • Employees 10
  • Website imipharma.com

Company Summary

Immune Modulation, Inc. is a Research & Development Bio-tech Company engaged in the development of promising new pharmaceuticals (Diterpenes) from natural bioresources to treat and prevent a variety of human diseases for which there is an unmet medical need. The customers for these novel therapeutic natural products are the big pharmaceutical companies who rely on in-licensing of certain proprietary pharmaceuticals.

Team

  • Default avatar
    Emmanuel A. Ojo-Amaize, Ph.D.
    Chairman, President & CEO

    Dr. Ojo-Amaize received his B.A. degree in Biology/Biochemistry from Prescott College, Prescott, Arizona, a Ph.D. degree in Cellular Immunology from Uppsala University, Uppsala, Sweden and a Postdoctoral training in Molecular Immunology & Parasitology from New York University, New York, NY. He previously held executive and management positions at Specialty Laboratories, Inc., and ICN Pharmaceuticals, Inc. Prior to ICN, He was a Fellow at UCLA.

  • Default avatar
    Howard B. Cottam, Ph.D.
    Director, Vice President & COO

    Dr. Cottam received his B.S. Degree in Chemistry from ASU in Tempe, Arizona, a Ph.D. in Organic Chemistry from BYU and postdoctoral training in Medicinal Chemistry from BYU Cancer Research Center. Dr. Cottam was most recently Director, Medicinal Chemistry, at The Sam and Rose Stein Inst. at UCSD in San Diego, CA. He previously held an executive position at ICN Pharmaceuticals, Inc. and served as a Consultant to Specialty Laboratories, Inc.

  • Default avatar
    Emeka J. Nchekwube, M.D.
    Director, Chief Medical Officer & Secretary

    Dr. Nchekwube received his B.S. degree in Chemistry from Central Michigan University and M.D. from Wayne State University School of Medicine in Detroit, Michigan. He has served as a member of the Board of Directors of several firms including Providence Farms, Inc., Beacon Diagnostics and Quinta Naturaceuticals, Inc. He is an active member of several professional societies including: AMA, CMA and Congress of Neurological Surgeons.

Advisors

  • Default avatar
    William R. Black, Attorney At Law. 44 Panorama, Coto de Caza, CA 92679
    Lawyer
    Unconfirmed
    Default avatar
    Ulysses S. Curry, Jr., MBA, Cogent Advisors, 8447 Wilshire Blvd. Ste # 401, Beverly Hills, CA 90211
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Specialty Laboratories, Inc.
    Unconfirmed